TRAVERE THERAPEUTICS, INC. Notes Payable, Current
TRAVERE THERAPEUTICS, INC. (TVTX) had Notes Payable, Current of $0 as of 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2016-02-26
- 2015-12-31: Notes Payable, Current $0.00.
- 2015-09-30: Notes Payable, Current $0.00.
- 2015-06-30: Notes Payable, Current $41.13M.
- 2014-12-31: Notes Payable, Current $40.49M; Notes Payable, Current as first filed $40.49M.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-26 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $41.13M 10-Q · filed 2015-08-10 | |
| 2014-12-31 | $40.49M 10-K · filed 2016-02-26 | $40.49M 10-K · filed 2015-03-11 |
| 2014-06-30 | $39.83M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $31.28M 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |